HIV Diagnostics Market by Product (Assay Kits & Reagents, Instrument, Software), Test Type (Rapid Test, ELISA, Western Blot, Viral Load, CD4 Test), End User (Diagnostic Laboratories, Homecare Settings, Hospital) - Global Forecast to 2030

1.1 Study Objectives
1.2 Market Definition
1.3 Market Scope
1.3.1 Market Segmentation
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.3.4 Currency Considered
1.4 Stakeholders
1.5 Summary of Changes

2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Key Data from Primary Sources
2.1.2.4 Breakdown of Primary Interviews
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.1.1 Approach 1: Company Revenue Estimation Approach
2.2.1.2 Approach 2: Presentations of Companies and Primary Interviews
2.2.1.3 Growth Forecast
2.2.1.4 CAGR Projections
2.2.2 Top-Down Approach
2.3 Market Breakdown & Data Triangulation
2.4 Market Share Assumptions
2.5 Study Assumptions
2.6 Research Limitations
2.7 Risk Assessment

4.1 HIV Diagnostics Market Overview
4.2 Geographic Growth Opportunities

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Prevalence of HIV/Aids
5.2.1.2 Increasing Number of Blood Transfusions & Blood Donations
5.2.1.3 Advantages Offered by Poc Diagnostic Kits & Instruments
5.2.1.4 Increasing Initiatives for HIV Awareness Campaigns
5.2.2 Restraints
5.2.2.1 High Cost of Nats
5.2.3 Opportunities
5.2.3.1 High Growth Potential of Emerging Economies
5.2.3.2 Trend of Self-Testing and Growing Preference for At- Home Diagnostic Kits
5.2.4 Challenges
5.2.4.1 Operational Barriers and Shortage of Skilled Laboratory Technicians
5.3 Trends/Disruptions Impacting Customers’ Businesses
5.4 Pricing Analysis
5.4.1 Average Selling Price of HIV Diagnostic Products, by Key Player, 2023
5.4.2 Average Selling Price Trend, by Test Type, 2021-2023
5.4.3 Average Selling Price Trend of HIV Diagnostic Instruments, by Region, 2021-2023 (USD)
5.5 Value Chain Analysis
5.6 Supply Chain Analysis
5.7 Ecosystem Analysis
5.8 Technology Analysis
5.8.1 Key Technologies
5.8.1.1 Elisa
5.8.2 Complementary Technologies
5.8.2.1 Western Blot Tests
5.8.3 Adjacent Technologies
5.8.3.1 Pcr
5.9 Investment & Funding Scenario
5.10 Patent Analysis
5.11 Trade Analysis
5.11.1 Import Data for HS Code 3822
5.11.2 Export Data for HS Code 3822
5.12 Key Conferences & Events, 2025-2026
5.13 Case Study Analysis
5.13.1 Role of Community-based Organizations (Cbos) in Supporting People with HIV
5.13.2 Managing High Blood Pressure and Blood Sugar in HIV-Positive Patients
5.14 Regulatory Landscape
5.14.1 Regulatory Bodies, Government Agencies, and Other Organizations
5.14.2 Regulatory Framework
5.14.2.1 North America
5.14.2.1.1 US
5.14.2.1.2 Canada
5.14.2.2 Europe
5.14.2.3 Asia-Pacific
5.14.2.3.1 China
5.14.2.3.2 Japan
5.14.2.3.3 India
5.14.2.4 Latin America
5.14.2.4.1 Brazil
5.14.2.4.2 Mexico
5.14.2.5 Middle East
5.14.2.6 Africa
5.15 Porter's Five Forces Analysis
5.15.1 Threat of New Entrants
5.15.2 Threat of Substitutes
5.15.3 Bargaining Power of Buyers
5.15.4 Bargaining Power of Suppliers
5.15.5 Intensity of Competitive Rivalry
5.16 Key Stakeholders & Buying Criteria
5.16.1 Key Stakeholders in Buying Process
5.16.2 Key Buying Criteria, by Product
5.17 Impact of AI/Generative AI on HIV Diagnostics Market
5.17.1 Market Potential of AI in HIV Diagnostics
5.17.2 AI Use Cases
5.17.3 Company Implementation of AI
5.17.4 Future of AI/Generative AI

6.1 Introduction
6.2 Screening Tests
6.2.1 Rapid Tests
6.2.1.1 Provision of Quick Test Results and Ability to Diagnose HIV Antibodies to Fuel Uptake
6.2.2 Elisa
6.2.2.1 Wide Applications Across Infectious Disease Diagnostics to Drive Market
6.2.3 Other Screening Tests
6.3 Confirmatory Tests
6.3.1 Western Blot Tests
6.3.1.1 Gold Standard Testing for Result Validation to Drive Market
6.3.2 Other Confirmatory Tests
6.4 Monitoring Tests
6.4.1 Viral Load Tests
6.4.1.1 Accurate Provision of Quantitative Data on HIV Infections to Boost Demand
6.4.2 Cd4 Tests
6.4.2.1 Ability to Number Cd4 T Lymphocyte Cells to Support Market Growth
6.5 Other HIV Diagnostic Tests

7.1 Introduction
7.1.1 Consumables
7.1.2 Assay Kits & Reagents
7.1.2.1 Recurrent Purchase to Fuel Market
7.1.3 Other Consumables
7.2 Instruments
7.2.1 Rising Technological Advancements to Drive Market
7.3 Software & Services
7.3.1 Increasing Demand for Value-Added Services & Automated Software to Support Market Growth

8.1 Introduction
8.2 Diagnostic Laboratories
8.2.1 High Volume of HIV Testing Samples to Propel Market
8.3 Hospitals
8.3.1 Increasing Adoption of Diagnostic Tools and Favorable Reimbursements to Drive Market
8.4 Blood Banks
8.4.1 Rising Number of Blood Donations to Boost Demand
8.5 Home Care Settings
8.5.1 Increasing Preference for At-Home Testing Kits to Support Market Growth
8.6 Other End-users

9.1 Introduction
9.2 North America
9.2.1 Macroeconomic Outlook for North America
9.2.2 US
9.2.2.1 High Healthcare Expenditure to Drive Market
9.2.3 Canada
9.2.3.1 Increasing Number of HIV Infections and Blood Donations to Drive Market
9.3 Europe
9.3.1 Macroeconomic Outlook for Europe
9.3.2 Germany
9.3.2.1 Favorable Government Healthcare Policies and Reimbursements for HIV Testing to Drive Market
9.3.3 UK
9.3.3.1 Rising Government Support for HIV Awareness Campaigns to Support Market Growth
9.3.4 France
9.3.4.1 High Prevalence of HIV/Aids to Boost Demand
9.3.5 Italy
9.3.5.1 Increasing Number of Blood Donors to Support Market Growth
9.3.6 Spain
9.3.6.1 Rising Adoption of Nat Technology to Propel Market
9.3.7 Rest of Europe
9.4 Asia-Pacific
9.4.1 Macroeconomic Outlook for Asia-Pacific
9.4.2 China
9.4.2.1 Rising Incidence of Infectious Diseases & HIV to Propel Market
9.4.3 Japan
9.4.3.1 Growing Adoption of Advanced HIV Screening Technologies to Drive Market
9.4.4 India
9.4.4.1 Government Initiatives Such as Free HIV Testing to Drive Market
9.4.5 Rest of Asia-Pacific
9.5 Latin America
9.5.1 Macroeconomic Outlook for Latin America
9.5.2 Brazil
9.5.2.1 Increasing Uptake of Technologically Advanced Blood Screening Tests to Drive Market
9.5.3 Mexico
9.5.3.1 Rising Establishment of Blood Banks to Support Market Growth
9.5.4 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Rising Number of HIV Diagnostics and Surgical Procedures to Fuel Market
9.6.2 Macroeconomic Outlook for Middle East & Africa
9.7 GCC Countries
9.7.1 Rising Focus on HIV Testing and Improvements in Healthcare Infrastructure to Support Market Growth
9.7.2 Macroeconomic Outlook for GCC Countries

10.1 Overview
10.2 Key Player Strategies/Right to Win
10.2.1 Overview of Strategies Adopted by Key Players in HIV Diagnostics Market
10.3 Revenue Analysis, 2021-2023
10.4 Market Share Analysis, 2023
10.4.1 Ranking of Key Market Players
10.5 Company Evaluation Matrix: Key Players, 2023
10.5.1 Stars
10.5.2 Emerging Leaders
10.5.3 Pervasive Players
10.5.4 Participants
10.5.5 Company Footprint: Key Players, 2023
10.5.5.1 Company Footprint
10.5.5.2 Region Footprint
10.5.5.3 Product Footprint
10.5.5.4 End-user Footprint
10.6 Company Evaluation Matrix: Startups/SMEs, 2023
10.6.1 Progressive Companies
10.6.2 Responsive Companies
10.6.3 Dynamic Companies
10.6.4 Starting Blocks
10.6.5 Competitive Benchmarking: Startups/SMEs, 2023
10.6.5.1 Detailed List of Key Startups/SME Players
10.6.5.2 Competitive Benchmarking of Key Startups/SMEs
10.7 Company Valuation & Financial Metrics
10.8 Brand/Product Comparison
10.9 Competitive Scenario
10.9.1 Product/Service Launches & Approvals
10.9.2 Product Launches & Approvals
10.9.3 Deals
10.9.4 Expansions
10.9.5 Other Developments

11.1 Key Players
11.1.1 Abbott
11.1.1.1 Business Overview
11.1.1.2 Products/Services Offered
11.1.1.3 Recent Developments
11.1.1.3.1 Deals
11.1.1.4 Analyst's View
11.1.1.4.1 Key Strengths
11.1.1.4.2 Strategic Choices
11.1.1.4.3 Weaknesses & Competitive Threats
11.1.2 Siemens Healthineers
11.1.2.1 Business Overview
11.1.2.2 Products/Services Offered
11.1.2.3 Recent Developments
11.1.2.3.1 Product/Service Launches & Approvals
11.1.2.3.2 Deals
11.1.2.3.3 Other Developments
11.1.2.4 Analyst's View
11.1.2.4.1 Key Strengths
11.1.2.4.2 Strategic Choices
11.1.2.4.3 Weaknesses & Competitive Threats
11.1.3 Grifols, SA
11.1.3.1 Business Overview
11.1.3.2 Products/Services Offered
11.1.3.3 Recent Developments
11.1.3.3.1 Deals
11.1.3.4 Analyst's View
11.1.3.4.1 Key Strengths
11.1.3.4.2 Strategic Choices
11.1.3.4.3 Weaknesses & Competitive Threats
11.1.4 Danaher Corporation
11.1.4.1 Business Overview
11.1.4.2 Products/Services Offered
11.1.4.3 Recent Developments
11.1.4.3.1 Product Launches & Approvals
11.1.4.3.2 Deals
11.1.4.3.3 Expansions
11.1.4.4 Analyst's View
11.1.4.4.1 Key Strengths
11.1.4.4.2 Strategic Choices
11.1.4.4.3 Weaknesses & Competitive Threats
11.1.5 Thermo Fisher Scientific Inc.
11.1.5.1 Business Overview
11.1.5.2 Products/Services Offered
11.1.5.3 Recent Developments
11.1.5.3.1 Product/Service Launches & Approvals
11.1.5.3.2 Deals
11.1.5.4 Analyst's View
11.1.5.4.1 Key Strengths
11.1.5.4.2 Strategic Choices
11.1.5.4.3 Weaknesses & Competitive Threats
11.1.6 Bio-Rad Laboratories, Inc.
11.1.6.1 Business Overview
11.1.6.2 Products/Services Offered
11.1.6.2.1 Deals
11.1.7 F. Hoffmann-La Roche Ltd.
11.1.7.1 Business Overview
11.1.7.2 Products/Services Offered
11.1.7.3 Recent Developments
11.1.7.3.1 Product Launches & Approvals
11.1.7.3.2 Deals
11.1.7.3.3 Expansions
11.2 Other Players
11.2.1 Biomérieux
11.2.2 Hologic, Inc.
11.2.3 Qiagen
11.2.4 Bd
11.2.5 Trinity Biotech
11.2.6 Orasure Technologies, Inc.
11.2.7 Biosynex SA
11.2.8 Wondfo
11.2.9 Getein Biotech, Inc.
11.2.10 Meril Life Sciences Pvt. Ltd.
11.2.11 Accubiotech Co. Ltd.
11.2.12 Biolytical Laboratories Inc.
11.2.13 Bio Lab Diagnostics (I) Private Limited
11.2.14 Alpine Biomedicals Pvt Ltd.
11.2.15 Molbio Diagnostics Pvt. Ltd.
11.2.16 Fortress Diagnostics
11.2.17 Advacare Pharma (Accuquik)
11.2.18 Adaltis S.R.L.

12.1 Discussion Guide
12.2 Knowledgestore: The Subscription Portal
12.3 Customization Options

Table 1 HIV Diagnostics Market: Inclusions & Exclusions
Table 2 HIV Diagnostics Market: Risk Assessment Analysis
Table 3 Number of People Living with HIV vs. New HIV Cases, by Region (2023)
Table 4 Average Selling Price of HIV Diagnostics Products, by Key Player, 2023
Table 5 Average Selling Price Trend, by Test Type, 2021-2023
Table 6 Average Selling Price Trend of HIV Diagnostic Instruments, by Region, 2021-2023 (USD)
Table 7 HIV Diagnostics Market: Role in Ecosystem
Table 8 HIV Diagnostics Market: Innovations & Patent Registrations, 2023-2024
Table 9 Import Data for HS Code 9021, by Country, 2019-2023 (USD Million)
Table 10 Export Data for HS Code 9021, by Country, 2019-2023 (USD Million)
Table 11 HIV Diagnostics Market: Key Conferences & Events, 2025-2026
Table 12 North America: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 13 Asia-Pacific: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 14 Latin America: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 15 Rest of the World: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 16 Europe: Classification of Devices
Table 17 Japan: Time, Cost, and Complexity of Registration Process
Table 18 HIV Diagnostics Market: Porter's Five Forces
Table 19 Influence of Stakeholders on Buying Process, by Product (%)
Table 20 Key Buying Criteria for Products, by Rank
Table 21 Company Implementation of AI in HIV Diagnostics Market
Table 22 HIV Diagnostics Market, by Test Type, 2022-2030 (USD Million)
Table 23 US: HIV Diagnostics Market, by Test Type, 2022-2030 (Million Tests)
Table 24 US: HIV Diagnostics Market, by Rapid Test Type, 2022-2030 (Million Tests)
Table 25 US: HIV Diagnostics Market, by Confirmatory Test Type, 2022-2030 (Million Tests)
Table 26 HIV Diagnostics Market for Screening Tests, by Type, 2022-2030 (USD Million)
Table 27 Screening Tests Market, by Region, 2022-2030 (USD Million)
Table 28 North America: Screening Tests Market, by Country, 2022-2030 (USD Million)
Table 29 Europe: Screening Tests Market, by Country, 2022-2030 (USD Million)
Table 30 Asia-Pacific: Screening Tests Market, by Country, 2022-2030 (USD Million)
Table 31 Latin America: Screening Tests Market, by Country, 2022-2030 (USD Million)
Table 32 Rapid Tests Market, by Region, 2022-2030 (USD Million)
Table 33 North America: Rapid Tests Market, by Country, 2022-2030 (USD Million)
Table 34 Europe: Rapid Tests Market, by Country, 2022-2030 (USD Million)
Table 35 Asia-Pacific: Rapid Tests Market, by Country, 2022-2030 (USD Million)
Table 36 Latin America: Rapid Tests Market, by Country, 2022-2030 (USD Million)
Table 37 Elisa Market, by Region, 2022-2030 (USD Million)
Table 38 North America: Elisa Market, by Country, 2022-2030 (USD Million)
Table 39 Europe: Elisa Market, by Country, 2022-2030 (USD Million)
Table 40 Asia-Pacific: Elisa Market, by Country, 2022-2030 (USD Million)
Table 41 Latin America: Elisa Market, by Country, 2022-2030 (USD Million)
Table 42 Other Screening Tests Market, by Region, 2022-2030 (USD Million)
Table 43 North America: Other Screening Tests Market, by Country, 2022-2030 (USD Million)
Table 44 Europe: Other Screening Tests Market, by Country, 2022-2030 (USD Million)
Table 45 Asia-Pacific: Other Screening Tests Market, by Country, 2022-2030 (USD Million)
Table 46 Latin America: Other Screening Tests Market, by Country, 2022-2030 (USD Million)
Table 47 Confirmatory Tests Market, by Type, 2022-2030 (USD Million)
Table 48 Confirmatory Tests Market, by Region, 2022-2030 (USD Million)
Table 49 North America: Confirmatory Tests Market, by Country, 2022-2030 (USD Million)
Table 50 Europe: Confirmatory Tests Market, by Country, 2022-2030 (USD Million)
Table 51 Asia-Pacific: Confirmatory Tests Market, by Country, 2022-2030 (USD Million)
Table 52 Latin America: Confirmatory Tests Market, by Country, 2022-2030 (USD Million)
Table 53 Western Blot Tests Market, by Region, 2022-2030 (USD Million)
Table 54 North America: Western Blot Tests Market, by Country, 2022-2030 (USD Million)
Table 55 Europe: Western Blot Tests Market, by Country, 2022-2030 (USD Million)
Table 56 Asia-Pacific: Western Blot Tests Market, by Country, 2022-2030 (USD Million)
Table 57 Latin America: Western Blot Tests Market, by Country, 2022-2030 (USD Million)
Table 58 Other Confirmatory Tests Market, by Region, 2022-2030 (USD Million)
Table 59 North America: Other Confirmatory Tests Market, by Country, 2022-2030 (USD Million)
Table 60 Europe: Other Confirmatory Tests Market, by Country, 2022-2030 (USD Million)
Table 61 Asia-Pacific: Other Confirmatory Tests Market, by Country, 2022-2030 (USD Million)
Table 62 Latin America: Other Confirmatory Tests Market, by Country, 2022-2030 (USD Million)
Table 63 Monitoring Tests Market, by Type, 2022-2030 (USD Million)
Table 64 Monitoring Tests Market, by Region, 2022-2030 (USD Million)
Table 65 North America: Monitoring Tests Market, by Country, 2022-2030 (USD Million)
Table 66 Europe: Monitoring Tests Market, by Country, 2022-2030 (USD Million)
Table 67 Asia-Pacific: Monitoring Tests Market, by Country, 2022-2030 (USD Million)
Table 68 Latin America: Monitoring Tests Market, by Country, 2022-2030 (USD Million)
Table 69 Viral Load Tests Market, by Region, 2022-2030 (USD Million)
Table 70 North America: Viral Load Tests Market, by Country, 2022-2030 (USD Million)
Table 71 Europe: Viral Load Tests Market, by Country, 2022-2030 (USD Million)
Table 72 Asia-Pacific: Viral Load Tests Market, by Country, 2022-2030 (USD Million)
Table 73 Latin America: Viral Load Tests Market, by Country, 2022-2030 (USD Million)
Table 74 Cd4 Tests Market, by Region, 2022-2030 (USD Million)
Table 75 North America: Cd4 Tests Market, by Country, 2022-2030 (USD Million)
Table 76 Europe: Cd4 Tests Market, by Country, 2022-2030 (USD Million)
Table 77 Asia-Pacific: Cd4 Tests Market, by Country, 2022-2030 (USD Million)
Table 78 Latin America: Cd4 Tests Market, by Country, 2022-2030 (USD Million)
Table 79 Other HIV Diagnostic Tests Market, by Region, 2022-2030 (USD Million)
Table 80 North America: Other HIV Diagnostic Tests Market, by Country, 2022-2030 (USD Million)
Table 81 Europe: Other HIV Diagnostic Tests Market, by Country, 2022-2030 (USD Million)
Table 82 Asia-Pacific: Other HIV Diagnostic Tests Market, by Country, 2022-2030 (USD Million)
Table 83 Latin America: Other HIV Diagnostic Tests Market, by Country, 2022-2030 (USD Million)
Table 84 HIV Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 85 HIV Diagnostics Market for Consumables Market, by Type, 2022-2030 (USD Million)
Table 86 HIV Diagnostics Market for Consumables, by Region, 2022-2030 (USD Million)
Table 87 North America: HIV Diagnostics Market for Consumables, by Country, 2022-2030 (USD Million)
Table 88 Europe: HIV Diagnostics Market for Consumables, by Country, 2022-2030 (USD Million)
Table 89 Asia-Pacific: HIV Diagnostics Market for Consumables, by Country, 2022-2030 (USD Million)
Table 90 Latin America: HIV Diagnostics Market for Consumables, by Country, 2022-2030 (USD Million)
Table 91 Assay Kits & Reagents Offered by Key Players
Table 92 Assay Kits & Reagents Market, by Region, 2022-2030 (USD Million)
Table 93 North America: Assay Kits & Reagents Market, by Country, 2022-2030 (USD Million)
Table 94 Europe: Assay Kits & Reagents Market, by Country, 2022-2030 (USD Million)
Table 95 Asia-Pacific: Assay Kits & Reagents Market, by Country, 2022-2030 (USD Million)
Table 96 Latin America: Assay Kits & Reagents Market, by Country, 2022-2030 (USD Million)
Table 97 Other Consumables Market, by Region, 2022-2030 (USD Million)
Table 98 North America: Other Consumables Market, by Country, 2022-2030 (USD Million)
Table 99 Europe: Other Consumables Market, by Country, 2022-2030 (USD Million)
Table 100 Asia-Pacific: Other Consumables Market, by Country, 2022-2030 (USD Million)
Table 101 Latin America: Other Consumables Market, by Country, 2022-2030 (USD Million)
Table 102 Key Instruments Available in HIV Diagnostics Market
Table 103 HIV Diagnostics Market for Instruments, by Region, 2022-2030 (USD Million)
Table 104 North America: HIV Diagnostics Market for Instruments, by Country, 2022-2030 (USD Million)
Table 105 Europe: HIV Diagnostics Market for Instruments, by Country, 2022-2030 (USD Million)
Table 106 Asia-Pacific: HIV Diagnostics Market for Instruments, by Country, 2022-2030 (USD Million)
Table 107 Latin America: HIV Diagnostics Market for Instruments, by Country, 2022-2030 (USD Million)
Table 108 HIV Diagnostics Market for Software & Services, by Region, 2022-2030 (USD Million)
Table 109 North America: HIV Diagnostics Market for Software & Services, by Country, 2022-2030 (USD Million)
Table 110 Europe: HIV Diagnostics Market for Software & Services, by Country, 2022-2030 (USD Million)
Table 111 Asia-Pacific: HIV Diagnostics Market for Software & Services, by Country, 2022-2030 (USD Million)
Table 112 Latin America: HIV Diagnostics Market for Software & Services, by Country, 2022-2030 (USD Million)
Table 113 HIV Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 114 Diagnostic Laboratories Market, by Region, 2022-2030 (USD Million)
Table 115 North America: Diagnostic Laboratories Market, by Country, 2022-2030 (USD Million)
Table 116 Europe: Diagnostic Laboratories Market, by Country, 2022-2030 (USD Million)
Table 117 Asia-Pacific: Diagnostic Laboratories Market, by Country, 2022-2030 (USD Million)
Table 118 Latin America: Diagnostic Laboratories Market, by Country, 2022-2030 (USD Million)
Table 119 Hospitals Market, by Region, 2022-2030 (USD Million)
Table 120 North America: Hospitals Market, by Country, 2022-2030 (USD Million)
Table 121 Europe: Hospitals Market, by Country, 2022-2030 (USD Million)
Table 122 Asia-Pacific: Hospitals Market, by Country, 2022-2030 (USD Million)
Table 123 Latin America: Hospitals Market, by Country, 2022-2030 (USD Million)
Table 124 Blood Banks Market, by Region, 2022-2030 (USD Million)
Table 125 North America: Blood Banks Market, by Country, 2022-2030 (USD Million)
Table 126 Europe: Blood Banks Market, by Country, 2022-2030 (USD Million)
Table 127 Asia-Pacific: Blood Banks Market, by Country, 2022-2030 (USD Million)
Table 128 Latin America: Blood Banks Market, by Country, 2022-2030 (USD Million)
Table 129 Home Care Settings Market, by Region, 2022-2030 (USD Million)
Table 130 North America: Home Care Settings Market, by Country, 2022-2030 (USD Million)
Table 131 Europe: Home Care Settings Market, by Country, 2022-2030 (USD Million)
Table 132 Asia-Pacific: Home Care Settings Market, by Country, 2022-2030 (USD Million)
Table 133 Latin America: Home Care Settings Market, by Country, 2022-2030 (USD Million)
Table 134 Other End-users Market, by Region, 2022-2030 (USD Million)
Table 135 North America: Other End-users Market, by Country, 2022-2030 (USD Million)
Table 136 Europe: Other End-users Market, by Country, 2022-2030 (USD Million)
Table 137 Asia-Pacific: Other End-users Market, by Country, 2022-2030 (USD Million)
Table 138 Latin America: Other End-users Market, by Country, 2022-2030 (USD Million)
Table 139 HIV Diagnostics Market, by Region, 2022-2030 (USD Million)
Table 140 North America: HIV Diagnostics Market, by Country, 2022-2030 (USD Million)
Table 141 North America: HIV Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 142 North America: HIV Diagnostics Market for Consumables, by Type, 2022-2030 (USD Million)
Table 143 North America: HIV Diagnostics Market, by Test Type, 2022-2030 (USD Million)
Table 144 North America: Screening Tests Market, by Type, 2022-2030 (USD Million)
Table 145 North America: Confirmatory Tests Market, by Type, 2022-2030 (USD Million)
Table 146 North America: Monitoring Tests Market, by Type, 2022-2030 (USD Million)
Table 147 North America: HIV Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 148 US: HIV Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 149 US: HIV Diagnostics Market for Consumables, by Type, 2022-2030 (USD Million)
Table 150 US: HIV Diagnostics Market, by Test Type, 2022-2030 (USD Million)
Table 151 US: Screening Tests Market, by Type, 2022-2030 (USD Million)
Table 152 US: Confirmatory Tests Market, by Type, 2022-2030 (USD Million)
Table 153 US: Monitoring Tests Market, by Type, 2022-2030 (USD Million)
Table 154 US: HIV Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 155 Canada: HIV Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 156 Canada: HIV Diagnostics Market for Consumables, by Type, 2022-2030 (USD Million)
Table 157 Canada: HIV Diagnostics Market, by Test Type, 2022-2030 (USD Million)
Table 158 Canada: Screening Tests Market, by Type, 2022-2030 (USD Million)
Table 159 Canada: Confirmatory Tests Market, by Type, 2022-2030 (USD Million)
Table 160 Canada: Monitoring Tests Market, by Type, 2022-2030 (USD Million)
Table 161 Canada: HIV Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 162 Europe: HIV Diagnostics Market, by Country, 2022-2030 (USD Million)
Table 163 Europe: HIV Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 164 Europe: HIV Diagnostics Market for Consumables, by Type, 2022-2030 (USD Million)
Table 165 Europe: HIV Diagnostics Market, by Test Type, 2022-2030 (USD Million)
Table 166 Europe: Screening Tests Market, by Type, 2022-2030 (USD Million)
Table 167 Europe: Confirmatory Tests Market, by Type, 2022-2030 (USD Million)
Table 168 Europe: Monitoring Tests Market, by Type, 2022-2030 (USD Million)
Table 169 Europe: HIV Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 170 Germany: HIV Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 171 Germany: HIV Diagnostics Market for Consumables, by Type, 2022-2030 (USD Million)
Table 172 Germany: HIV Diagnostics Market, by Test Type, 2022-2030 (USD Million)
Table 173 Germany: Screening Tests Market, by Type, 2022-2030 (USD Million)
Table 174 Germany: Confirmatory Tests Market, by Type, 2022-2030 (USD Million)
Table 175 Germany: Monitoring Tests Market, by Type, 2022-2030 (USD Million)
Table 176 Germany: HIV Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 177 UK: HIV Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 178 UK: HIV Diagnostics Market for Consumables, by Type, 2022-2030 (USD Million)
Table 179 UK: HIV Diagnostics Market, by Test Type, 2022-2030 (USD Million)
Table 180 UK: Screening Tests Market, by Type, 2022-2030 (USD Million)
Table 181 UK: Confirmatory Tests Market, by Type, 2022-2030 (USD Million)
Table 182 UK: Monitoring Tests Market, by Type, 2022-2030 (USD Million)
Table 183 UK: HIV Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 184 France: HIV Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 185 France: HIV Diagnostics Market for Consumables, by Type, 2022-2030 (USD Million)
Table 186 France: HIV Diagnostics Market, by Test Type, 2022-2030 (USD Million)
Table 187 France: Screening Tests Market, by Type, 2022-2030 (USD Million)
Table 188 France: Confirmatory Tests Market, by Type, 2022-2030 (USD Million)
Table 189 France: Monitoring Tests Market, by Type, 2022-2030 (USD Million)
Table 190 France: HIV Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 191 Italy: HIV Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 192 Italy: HIV Diagnostics Market for Consumables, by Type, 2022-2030 (USD Million)
Table 193 Italy: HIV Diagnostics Market, by Test Type, 2022-2030 (USD Million)
Table 194 Italy: Screening Tests Market, by Type, 2022-2030 (USD Million)
Table 195 Italy: Confirmatory Tests Market, by Type, 2022-2030 (USD Million)
Table 196 Italy: Monitoring Tests Market, by Type, 2022-2030 (USD Million)
Table 197 Italy: HIV Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 198 Spain: HIV Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 199 Spain: HIV Diagnostics Market for Consumables, by Type, 2022-2030 (USD Million)
Table 200 Spain: HIV Diagnostics Market, by Test Type, 2022-2030 (USD Million)
Table 201 Spain: Screening Tests Market, by Type, 2022-2030 (USD Million)
Table 202 Spain: Confirmatory Tests Market, by Type, 2022-2030 (USD Million)
Table 203 Spain: Monitoring Tests Market, by Type, 2022-2030 (USD Million)
Table 204 Spain: HIV Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 205 Rest of Europe: HIV Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 206 Rest of Europe: HIV Diagnostics Market for Consumables, by Type, 2022-2030 (USD Million)
Table 207 Rest of Europe: HIV Diagnostics Market, by Test Type, 2022-2030 (USD Million)
Table 208 Rest of Europe: Screening Tests Market, by Type, 2022-2030 (USD Million)
Table 209 Rest of Europe: Confirmatory Tests Market, by Type, 2022-2030 (USD Million)
Table 210 Rest of Europe: Monitoring Tests Market, by Type, 2022-2030 (USD Million)
Table 211 Rest of Europe: HIV Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 212 Asia-Pacific: HIV Diagnostics Market, by Country, 2022-2030 (USD Million)
Table 213 Asia-Pacific: HIV Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 214 Asia-Pacific: HIV Diagnostics Market for Consumables, by Type, 2022-2030 (USD Million)
Table 215 Asia-Pacific: HIV Diagnostics Market, by Test Type, 2022-2030 (USD Million)
Table 216 Asia-Pacific: Screening Tests Market, by Type, 2022-2030 (USD Million)
Table 217 Asia-Pacific: Confirmatory Tests Market, by Type, 2022-2030 (USD Million)
Table 218 Asia-Pacific: Monitoring Tests Market, by Type, 2022-2030 (USD Million)
Table 219 Asia-Pacific: HIV Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 220 China: HIV Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 221 China: HIV Diagnostics Market for Consumables, by Type, 2022-2030 (USD Million)
Table 222 China: HIV Diagnostics Market, by Test Type, 2022-2030 (USD Million)
Table 223 China: Screening Tests Market, by Type, 2022-2030 (USD Million)
Table 224 China: Confirmatory Tests Market, by Type, 2022-2030 (USD Million)
Table 225 China: Monitoring Tests Market, by Type, 2022-2030 (USD Million)
Table 226 China: HIV Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 227 Japan: HIV Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 228 Japan: HIV Diagnostics Market for Consumables, by Type, 2022-2030 (USD Million)
Table 229 Japan: HIV Diagnostics Market, by Test Type, 2022-2030 (USD Million)
Table 230 Japan: Screening Tests Market, by Type, 2022-2030 (USD Million)
Table 231 Japan: Confirmatory Tests Market, by Type, 2022-2030 (USD Million)
Table 232 Japan: Monitoring Tests Market, by Type, 2022-2030 (USD Million)
Table 233 Japan: HIV Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 234 India: HIV Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 235 India: HIV Diagnostics Market for Consumables, by Type, 2022-2030 (USD Million)
Table 236 India: HIV Diagnostics Market, by Test Type, 2022-2030 (USD Million)
Table 237 India: Screening Tests Market, by Type, 2022-2030 (USD Million)
Table 238 India: Confirmatory Tests Market, by Type, 2022-2030 (USD Million)
Table 239 India: Monitoring Tests Market, by Type, 2022-2030 (USD Million)
Table 240 India: HIV Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 241 Rest of Asia-Pacific: HIV Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 242 Rest of Asia-Pacific: HIV Diagnostics Market for Consumables, by Type, 2022-2030 (USD Million)
Table 243 Rest of Asia-Pacific: HIV Diagnostics Market, by Test Type, 2022-2030 (USD Million)
Table 244 Rest of Asia-Pacific: Screening Tests Market, by Type, 2022-2030 (USD Million)
Table 245 Rest of Asia-Pacific: Confirmatory Tests Market, by Type, 2022-2030 (USD Million)
Table 246 Rest of Asia-Pacific: Monitoring Tests Market, by Type, 2022-2030 (USD Million)
Table 247 Rest of Asia-Pacific: HIV Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 248 Latin America: HIV Diagnostics Market, by Country, 2022-2030 (USD Million)
Table 249 Latin America: HIV Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 250 Latin America: HIV Diagnostics Market for Consumables, by Type, 2022-2030 (USD Million)
Table 251 Latin America: HIV Diagnostics Market, by Test Type, 2022-2030 (USD Million)
Table 252 Latin America: Screening Tests Market, by Type, 2022-2030 (USD Million)
Table 253 Latin America: Confirmatory Tests Market, by Type, 2022-2030 (USD Million)
Table 254 Latin America: Monitoring Tests Market, by Type, 2022-2030 (USD Million)
Table 255 Latin America: HIV Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 256 Brazil: HIV Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 257 Brazil: HIV Diagnostics Market for Consumables, by Type, 2022-2030 (USD Million)
Table 258 Brazil: HIV Diagnostics Market, by Test Type, 2022-2030 (USD Million)
Table 259 Brazil: Screening Tests Market, by Type, 2022-2030 (USD Million)
Table 260 Brazil: Confirmatory Tests Market, by Type, 2022-2030 (USD Million)
Table 261 Brazil: Monitoring Tests Market, by Type, 2022-2030 (USD Million)
Table 262 Brazil HIV Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 263 Mexico: HIV Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 264 Mexico: HIV Diagnostics Market for Consumables, by Type, 2022-2030 (USD Million)
Table 265 Mexico: HIV Diagnostics Market, by Test Type, 2022-2030 (USD Million)
Table 266 Mexico: Screening Tests Market, by Type, 2022-2030 (USD Million)
Table 267 Mexico: Confirmatory Tests Market, by Type, 2022-2030 (USD Million)
Table 268 Mexico: Monitoring Tests Market, by Type, 2022-2030 (USD Million)
Table 269 Mexico: HIV Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 270 Rest of Latin America: HIV Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 271 Rest of Latin America: HIV Diagnostics Market for Consumables, by Type, 2022-2030 (USD Million)
Table 272 Rest of Latin America: HIV Diagnostics Market, by Test Type, 2022-2030 (USD Million)
Table 273 Rest of Latin America: Screening Tests Market, by Type, 2022-2030 (USD Million)
Table 274 Rest of Latin America: Confirmatory Tests Market, by Type, 2022-2030 (USD Million)
Table 275 Rest of Latin America: Monitoring Tests Market, by Type, 2022-2030 (USD Million)
Table 276 Rest of Latin America: HIV Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 277 Middle East & Africa: HIV Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 278 Middle East & Africa: HIV Diagnostics Market for Consumables, by Type, 2022-2030 (USD Million)
Table 279 Middle East & Africa: HIV Diagnostics Market, by Test Type, 2022-2030 (USD Million)
Table 280 Middle East & Africa: Screening Tests Market, by Type, 2022-2030 (USD Million)
Table 281 Middle East & Africa: Confirmatory Tests Market, by Type, 2022-2030 (USD Million)
Table 282 Middle East & Africa: Monitoring Tests Market, by Type, 2022-2030 (USD Million)
Table 283 Middle East & Africa: HIV Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 284 Middle East & Africa: Macroeconomic Indicators
Table 285 GCC Countries: HIV Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 286 GCC Countries: HIV Diagnostics Market for Consumables, by Type, 2022-2030 (USD Million)
Table 287 GCC Countries: HIV Diagnostics Market, by Test Type, 2022-2030 (USD Million)
Table 288 GCC Countries: Screening Tests Market, by Type, 2022-2030 (USD Million)
Table 289 GCC Countries: Confirmatory Tests Market, by Type, 2022-2030 (USD Million)
Table 290 GCC Countries: Monitoring Tests Market, by Type, 2022-2030 (USD Million)
Table 291 GCC Countries: HIV Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 292 GCC Countries: Macroeconomic Indicators
Table 293 Overview of Strategies Adopted by Key Players in HIV Diagnostics Market
Table 294 HIV Diagnostics Market: Degree of Competition
Table 295 HIV Diagnostics Market: Region Footprint
Table 296 HIV Diagnostics Market: Product Footprint
Table 297 HIV Diagnostics Market: End-user Footprint
Table 298 HIV Diagnostics Market: Detailed List of Key Startups/SME Players
Table 299 HIV Diagnostics Market: Competitive Benchmarking of Key Startups/SMEs
Table 300 HIV Diagnostics Market: Product Launches & Approvals, January 2021-March 2025
Table 301 HIV Diagnostics Market: Deals, January 2021-March 2025
Table 302 HIV Diagnostics Market: Expansions, January 2021-March 2025
Table 303 HIV Diagnostics Market: Other Developments, January 2021-March 2025
Table 304 Abbott: Company Overview
Table 305 Abbott: Products/Services Offered
Table 306 Abbott: Deals, January 2021-January 2025
Table 307 Siemens Healthineers: Company Overview
Table 308 Grifols, SA: Company Overview
Table 309 Grifols, SA: Products/Services Offered
Table 310 Grifols, SA: Deals, January 2021- January 2025
Table 311 Danaher: Company Overview
Table 312 Danaher: Products/Services Offered
Table 313 Danaher: Product Launches & Approvals, January 2021-January 2025
Table 314 Danaher: Deals, January 2021-January 2025
Table 315 Danaher: Expansions, January 2021-January 2025
Table 316 Thermo Fisher Scientific Inc.: Company Overview
Table 317 Thermo Fisher Scientific Inc.: Products/Services Offered
Table 318 Thermo Fisher Scientific Inc.: Product/Service Launches & Approvals, January 2021-January 2025
Table 319 Thermo Fisher Scientific Inc.: Deals, January 2021-January 2025
Table 320 Bio-Rad Laboratories, Inc.: Company Overview
Table 321 Bio-Rad Laboratories, Inc.: Products/Services Offered
Table 322 Bio-Rad Laboratories, Inc.: Deals, January 2021- January 2025
Table 323 F. Hoffmann-La Roche Ltd..: Company Overview
Table 324 F. Hoffmann-La Roche Ltd..: Products/Services Offered
Table 325 F. Hoffmann-La Roche Ltd.: Product Launches & Approvals, January 2021-January 2025
Table 326 F. Hoffmann-La Roche Ltd..: Deals, January 2021- January 2025
Table 327 F. Hoffmann-La Roche Ltd..: Expansions, January 2021- January 2025
Table 328 Bd: Company Overview
Table 329 Trinity Biotech: Company Overview
Table 330 Biosynex SA: Company Overview
Table 331 Getein Biotech, Inc.: Company Overview
Table 332 Adaltis S.R.L.: Company Overview

Figure 1 Markets & Regions Covered
Figure 2 HIV Diagnostics Market: Research Design
Figure 3 Breakdown of Primary Interviews: by Company Type, Designation, and Region
Figure 4 Bottom-Up Approach: Company Revenue Estimation Approach
Figure 5 CAGR Projections: Supply-Side Analysis
Figure 6 HIV Diagnostics Market: Top-Down Approach
Figure 7 Data Triangulation Methodology
Figure 8 HIV Diagnostics Market: Study Assumptions
Figure 9 HIV Diagnostics Market, by Product, 2025 vs. 2030 (USD Million)
Figure 10 HIV Diagnostics Market, by Test Type, 2025 vs. 2030 (USD Million)
Figure 11 HIV Diagnostics Market, by End-user, 2025 vs. 2030 (USD Million)
Figure 12 HIV Diagnostics Market, by Region, 2025 vs. 2030 (USD Million)
Figure 13 Increasing Prevalence of HIV and Rising Blood Donations to Propel Market
Figure 14 HIV Diagnostics Market, by Product, 2025 vs. 2030 (USD Million)
Figure 15 HIV Diagnostics Market, by Test Type, 2025 vs. 2030 (USD Million)
Figure 16 HIV Diagnostics Screening Tests Market, by Type, 2025 vs. 2030 (USD Million)
Figure 17 HIV Diagnostics Confirmatory Tests Market, by Type, 2025 vs. 2030 (USD Million)
Figure 18 HIV Diagnostics Monitoring Tests Market, by Type, 2025 vs. 2030 (USD Million)
Figure 19 HIV Diagnostics Market, by End-user, 2025 vs. 2030 (USD Million)
Figure 20 Asia-Pacific Region to Grow at Highest CAGR During Forecast Period
Figure 21 HIV Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 22 New Revenue Pockets for Players in HIV Diagnostics Market
Figure 23 HIV Diagnostics Market: Value Chain Analysis
Figure 24 HIV Diagnostics Market: Supply Chain Analysis
Figure 25 HIV Diagnostics Market: Ecosystem Analysis
Figure 26 Investment & Funding Scenario, 2018-2025
Figure 27 HIV Diagnostics Market: Patent Analysis, January 2014-December 2024
Figure 28 HIV Diagnostics Market: Porter's Five Forces Analysis
Figure 29 Influence of Stakeholders on Buying Process, by Product
Figure 30 Key Buying Criteria, by Product
Figure 31 Market Potential of AI in HIV Diagnostics
Figure 32 HIV Diagnostics Market Segmentation, by Product
Figure 33 North America: HIV Diagnostics Market Snapshot
Figure 34 Asia-Pacific: HIV Diagnostics Market Snapshot
Figure 35 Revenue Analysis of Key Players in HIV Diagnostics Market, 2021-2023 (USD Million)
Figure 36 Market Share Analysis of Key Players in HIV Diagnostics Market (2023)
Figure 37 Ranking of Key Players in HIV Diagnostics Market, 2023
Figure 38 HIV Diagnostics Market: Company Evaluation Matrix (Key Players), 2023
Figure 39 HIV Diagnostics Market: Company Footprint
Figure 40 HIV Diagnostics Market: Company Evaluation Matrix (Startups/SMEs), 2023
Figure 41 EV/EBITDA of Key Vendors
Figure 42 Year-To-Date (Ytd) Price Total Return and 5-Year Stock Beta of Key Vendors
Figure 43 HIV Diagnostics Market: Brand/Product Comparative Analysis
Figure 44 Abbott: Company Snapshot (2023)
Figure 45 Siemens Healthineers: Company Snapshot (2023)
Figure 46 Grifols, SA: Company Snapshot (2023)
Figure 47 Danaher: Company Snapshot (2023)
Figure 48 Thermo Fisher Scientific Inc.: Company Snapshot (2023)
Figure 49 Bio-Rad Laboratories, Inc.: Company Snapshot (2023)
Figure 50 F. Hoffmann-La Roche Ltd.: Company Snapshot (2023)